on yesterdays news with ONTY /
It's not their drug and it's not a PR-worthy event.
They still effectively own half of it.
ONTY is running the trials through proof of concept. If that works, then both sides can take a 50% stake in the US (or N America, I forget) side. ARRY would take the ROW lead, with ONTY getting a percent of net.